Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065629 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marija Geroldinger-Simić und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Ordensklinikum Linz Elisabethinen, 4020 Linz, Austria. Hauptthemen laut MEDLINE: Autoimmune Diseases, Pulmonary Fibrosis, Scleroderma, Systemic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 "HEalth data Linkage for ClinicAL benefit" training network, under the Marie Skłodowska-Curie, Clinician scientist grant of the Austrian Society of Dermatology and Venereology, Postdoctoral scholarship for medical doctors in Upper Austria.
Abstract (Originalsprache)
Systemic sclerosis (SSc) is a rare autoimmune systemic disease that leads to decreased survival and quality of life due to fibrosis, inflammation, and vascular damage in the skin and/or vital organs. Early diagnosis is crucial for clinical benefit in SSc patients. Our study aimed to identify autoantibodies in the plasma of SSc patients that are associated with fibrosis in SSc. Initially, we performed a proteome-wide screening on sample pools from SSc patients by untargeted autoantibody screening on a planar antigen array (including 42,000 antigens representing 18,000 unique proteins). The selection was complemented with proteins reported in the literature in the context of SSc. A targeted antigen bead array was then generated with protein fragments representing the selected proteins and used to screen 55 SSc plasma samples and 52 matched controls. We found eleven autoantibodies with a higher prevalence in SSc patients than in controls, eight of which bound to proteins associated with fibrosis. Combining these autoantibodies in a panel could lead to the subgrouping of SSc patients with fibrosis. Anti-Phosphatidylinositol-5-phosphate 4-kinase type 2 beta (PIP4K2B)- and anti-AKT Serine/Threonine Kinase 3 (AKT3)-antibodies should be further explored to confirm their association with skin and lung fibrosis in SSc patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Ordensklinikum Linz Elisabethinen, 4020 Linz, Austria.
- Faculty of Medicine, Johannes Kepler University, 4040 Linz, Austria.
- Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65 Stockholm, Sweden.
ORCID-Profile: Marija Geroldinger-Simić, Shaghayegh Bayati, Elisa Pin
Förderung
- European Union's Horizon 2020 "HEalth data Linkage for ClinicAL benefit" training network, under the Marie Skłodowska-Curie
- Clinician scientist grant of the Austrian Society of Dermatology and Venereology
- Postdoctoral scholarship for medical doctors in Upper Austria
- Swedish Heart-Lung Foundation
- European Union’s Horizon 2020 “HEalth data Linkage for ClinicAL benefit” training network, under the Marie Skłodowska-Curie
Zitieren
APA
Geroldinger-Simić, M., Bayati, S., Pohjanen, E., Sepp, N., Nilsson, P., & Pin, E. (2023). Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065629
Vancouver
Geroldinger-Simić M, Bayati S, Pohjanen E, Sepp N, Nilsson P, Pin E. Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065629
BibTeX
@article{GeroldingerSimi2023,
author = {Geroldinger-Simić, Marija and Bayati, Shaghayegh and Pohjanen, Emmie and Sepp, Norbert and Nilsson, Peter and Pin, Elisa},
title = {Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065629}
}
EUVIMED